Health
NIAID set to conduct large monoclonal SARS-CoV-2 antibody clinical trial – News-Medical.Net
A large clinical trial, known as the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV-2), is set to take place, which aims to test monoclonal…
The coronavirus disease 2019 (COVID-19) pandemic continues to spread worldwide, with a new highly infectious strain identified in the UK, causing surges of new cases. Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), COVID-19 can cause mild to severe illness, while some do not experience any symptoms at all.
A large clinical trial, known as the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV-2), is set to take place, which aims to test monoclonal antibody…
-
Business18 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News18 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business22 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business21 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025